A

Avenue Therapeutics
D

ATXI

2.01000
USD
-0.02
(-0.99%)
Market Open
Volume
130
EPS
-20
Div Yield
-
P/E
0
Market Cap
3,842,382
OverviewSignalsIdeasNews
Related Instruments
    A
    AGIO
    -1.645
    (-2.97%)
    53.810 USD
    A
    ARWR
    -2.890
    (-13.49%)
    18.540 USD
    G
    GLYC
    0.02000
    (4.95%)
    0.42420 USD
    I
    INCY
    -1.840
    (-2.37%)
    75.890 USD
    K
    KPTI
    -0.02960
    (-3.54%)
    0.80740 USD
    M
    MGNX
    -0.23000
    (-6.04%)
    3.58000 USD
    R
    RARE
    -2.865
    (-6.02%)
    44.745 USD
    S
    SRPT
    -4.470
    (-4.10%)
    104.600 USD
    U
    UTHR
    -22.88
    (-5.92%)
    363.44 USD
    X
    XLRN
    0
    (0%)
    0.000000 USD
    More
News

Title: Avenue Therapeutics

Sector: Healthcare
Industry: Biotechnology
Avenue Therapeutics Inc is a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of rare and neurologic diseases. It focuses on developing its product candidate, AJ201, for spinal and bulbar muscular atrophy, BAER-101, for the treatment of epilepsy and panic disorders, and IV Tramadol for the management of moderate-to-moderately-severe pain in adults.